PEDIATRIC CLINICAL TRIALS MARKET ANALYSIS

Pediatric Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Treatment Studies and Observational Studies), By Therapeutic Area (Respiratory Diseases, Cardiovascular Diseases, and Neuropsychiatric Conditions, Oncology, Diabetes, and Others (Neuropsychiatric Conditions, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI397
Pages :313
Formats :
Excel and PDF
Industry : Pharmaceutical

Key Takeaways from Analyst

The global pediatric clinical trials market is expected to grow significantly in the coming years. The major driver for this growth will be the rising prevalence of chronic diseases among children. An increasing number of pediatric patients are suffering from cancer, neurological disorders, and genetic diseases.

Low market incentives for drug developers and extra logistic challenges in conducting pediatric trials may hamper the market growth. pediatric clinical trials require extra care, precautions and parents’ consent. Recruiting suitable pediatric participants is also difficult.

North America currently dominates the pediatric clinical trials landscape attributed to presence of major contract research organizations (CROs) and their expertise in pediatric. Stringent regulations in the U.S. and Canada have accelerated local research. Asia Pacific region is expected to show fastest growth in coming years. This is due to growing pediatric patient pool, increasing research investments and growing clinical research outsourcing to low cost Asian countries.